(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid (non-preferred name)(CAS: 1662688-20-1)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) (23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name)](https://cnstatic.chemtradehub.com/structs/166/1662688-20-1-2160.webp)
CAS号
相关产品
其他供应商提供的 (23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid (non-preferred name)
基本信息
分子式
C64H101N5O16
分子量
1196.53 g/mol
化学标识符
SMILES
CC(C)(C)OC(=O)[C@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)OCC1C2C=CC=CC=2C2C=CC=CC=21)C(O)=O)NC(=O)CCCCCCCCCCCCCCCCC(=O)OC(C)(C)C
InChIKey
COTQASXXEXJBOM-PJYGOTMFSA-N
数据库引用
MDL号
MFCD34563738
常见问题
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH是一种高分子量化合物,具有结晶形态。其分子量约为4349.7 g/mol。该化合物在水中溶解度较低,在有机溶剂如DMSO中有较好的溶解性。它表现出一定的反应活性,特别是酰胺键和酯键的反应。
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH通常通过固相肽合成法合成。首先,将Fmoc保护的L-Lys[Oct-(otBu)-Glu-(otBu)]残基固定在树脂上,然后逐步添加AEEA残基,使用标准的Fmoc固相肽合成条件,包括脱保护、缩合和洗涤步骤。常用的催化剂包括HOBt和DCC,产率可达85%以上。
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH主要用于药物化学和生物技术领域。它作为一种多肽类化合物,可以作为药物前体或作为研究工具用于蛋白质和多肽的合成与修饰。
处理该化合物时,应穿戴适当的个人防护装备(PPE),包括实验室外套、手套(推荐丁基橡胶手套)、护目镜和安全鞋。应在通风橱中操作,以避免吸入挥发性物质。如果发生泄漏,应立即移至安全区域,使用适当的吸收材料清理,并按照SDS(化学品安全数据表)中的指示处理废弃物。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
联系人
余经理
邮箱
710378061@qq.com
手机
18605105771
地址
上海市金山区金山卫镇秋实路688号1号楼



![5-Bromo-6-fluoro-1H-pyrrolo[2,3-b]pyridine](https://cnstatic.chemtradehub.com/structs/120/1207625-29-3-38b4.webp)



![Ethyl 2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl}amino)-2-oxoethyl]benzoate](https://cnstatic.chemtradehub.com/structs/147/147770-06-7-5fb6.webp)
![2-Methyl[1,3]oxazolo[5,4-d]pyrimidin-7(6H)-one](https://cnstatic.chemtradehub.com/structs/274/27433-55-2-83e8.webp)

![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — 张家界恒康生物药业有限公司](https://cnstatic.chemtradehub.com/suppliers/67cdfb6057537e5c8069b0a1/67cdfb6057537e5c8069b0a1-logo.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — 北京中硕医药科技开发有限公司](https://cnstatic.chemtradehub.com/suppliers/67cdf59457537e5c8069b02c/67cdf59457537e5c8069b02c-logo.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — 湖北扬信医药科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cded3957537e5c8069af88/67cded3957537e5c8069af88-logo.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — 南京肽业生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cdfc1057537e5c8069b0ad/67cdfc1057537e5c8069b0ad-logo.webp)